• Study Resource
  • Explore
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Viruses and Bacteria - Fort Bend ISD / Homepage
Viruses and Bacteria - Fort Bend ISD / Homepage

... white blood cells that protect us from infection. HIV attacks the T cell of the immune system. ...
Health_Unit4_Exam
Health_Unit4_Exam

... Each T/F question is worth 2 points Learning Objective 4-1: Identify different infectious diseases and their causes, including pathogens. 1) Infectious diseases can be spread by food and air. *a. True b. False 2) Protozoans are multiple-celled organisms. a. True *b. False 3) With this type of pathog ...
2.7 - mikrobiol unsoed
2.7 - mikrobiol unsoed

... or more molecules of DNA or RNA enclosed in a coat of protein, and sometimes in more complex layers b. With one known exception, virions contain either DNA or RNA, but not both c. They are obligate intracellular parasites ...
New Potential Lung Cancer Biomarkers Identified
New Potential Lung Cancer Biomarkers Identified

... “Drug resistance emergence is a common problem that limits long term outcome benefits in the era of precision cancer therapy,” commented Erin Seeley, PhD., Clinical Imaging Principal Investigator at Protea. She added, “Today we present the use of our mass spectrometry imaging (MSI) technology to int ...
Emergence of new pathogens `Viruses`
Emergence of new pathogens `Viruses`

... emergence; – (2) integrate laboratory science and epidemiology to optimize public health practice; – (3) enhance communication of public health information about emerging diseases and ensure prompt implementation prevention strategies; and – (4) strengthen local, state, and national public health in ...
bacteria-matrix
bacteria-matrix

... making a rap, song or skit. ...
Influenza virus:
Influenza virus:

... can occur due to mutation in sequence of amino acids in proteins of H and N . The mutation leads to change in antigenic nature of H or N or both ...
AFRICAN HORSE SICKNESS
AFRICAN HORSE SICKNESS

... even the heart and lungs. 80% of all viruses also replicate and initially live in the intestine which ties their host to possible parasites. We know that utilising anti-biotics kills good and bad bacteria and therefore damages the intestinal flora causing all kinds of havoc. It doesn’t matter what c ...
General structure and classification of viruses
General structure and classification of viruses

... 1899-1972: Max Theiler Propagate yellow fever virus in chicken embryos and successfully produced an attenuated vaccine [Theiler's vaccine was so safe and effective that it is still in use today] 1) Saved millions of lives 2) Set the model for the production of many subsequent vaccines (Nobel Prize i ...
Immunocore Announces Positive Clinical Trial Data for Novel First
Immunocore Announces Positive Clinical Trial Data for Novel First

... Immunocore’s proprietary technology is focused on small protein molecules called ImmTACs (Immune mobilising mTCR Against Cancer) that enable the immune system to recognise and kill cancerous cells. Immunocore's ImmTACs, a new class of drug with ultra-high affinity for intracellular cancer targets, a ...
Cell
Cell

... Percivall Pott found that chimney sweeps show substantially higher rates of skin cancer ...
Chapter 13
Chapter 13

... dsDNA Viruses – similar to normal replication of host cellular DNA ssDNA – in humans are paroviruses ...
Section 18.2 Summary – pages 484-495
Section 18.2 Summary – pages 484-495

... • Prokaryotic cells have ribosomes, but their ribosomes are smaller than those of eukaryotes. ...
PHA 321 - Biosciences II
PHA 321 - Biosciences II

... D) cytokines. 2. The complement pathway that requires antibodies to be activated is the A) alternate pathway. C) antibody pathway. B) classical pathway. D) inflammatory pathway. 3. The complement pathway that is activated by binding of C3b to cell surfaces is the A) classical pathway. C) C3b pathway ...
Biology First Six Weeks Vocabulary
Biology First Six Weeks Vocabulary

... A non-living particle dependent on host cells for replicating the viral DNA DNA, RNA and nucleic acids The process of immunity through introducing small doses of the infection Lives in or on another organism that results in harm to the host organism Protein coat that surrounds the genetic material o ...
Impaired TLR3-dependent induction of IFN-a, -b,
Impaired TLR3-dependent induction of IFN-a, -b,

... infection upon encountering an epithelial or mucosal cell. ...
Lesson Plan BISP Characterisation Clothes
Lesson Plan BISP Characterisation Clothes

... Go through worksheet answers as a way of recapping previous lesson. Tell them that this lesson we’ll be looking at the structure of viruses and how the structure is important for function. We’re going to make a model of a virus and we’ll use Dengue Virus as an example. What do viruses look like? (St ...
Viral pathogenesis
Viral pathogenesis

... VACCINE DEVELOPMENT Vaccination causing immunization can be either active or passive. •Active immunization – antigen is administered and causes the onset of the immune response •Passive immunization – a preformed antiviral product, such as antibody, is administered. ...
Duck Viral Enteritis (Duck plague) Duck viral enteritis (DVE) is an
Duck Viral Enteritis (Duck plague) Duck viral enteritis (DVE) is an

... necrotic and hemorrhagic enteritis, trauma, drake damage, and various toxicoses. Newcastle disease, avian influenza, and fowlpox may cause similar lesions but are rarely reported in ducks. Established cases should be reported to the appropriate regulatory agency . Prevention, Treatment, and Control ...
Viral Structure Virion, protein capsid, some have lipid envelope
Viral Structure Virion, protein capsid, some have lipid envelope

... Infectious RNA molecules Circular single stranded RNA with extensive base pairing Much smaller than RNA genome of viruses Do not encode proteins, although do have ribozyme  activity • Ribozyme: RNA with nuclease activity • Replicate using ribozyme activity and host enzymes  • Plant pathogens • Cause ...
Post-doctoral Research Associate in Structural Virology
Post-doctoral Research Associate in Structural Virology

... ion beam milling to determine three-dimensional structures of viruses and study their interactions with infected cells. We aim to provide structural information for development of anti-viral drugs. We study viruses from families Picornaviridae including human rhinoviruses type C and Flaviviridae inc ...
Gastrointestinal infectious virus
Gastrointestinal infectious virus

... • a group of viruses that parasitize the enteric tract and cause diseases. • fecal-oral route ...
Exam #2 F 3/30 in WCH 1.120 Review Th 3/29 at 5pm in GRG 102
Exam #2 F 3/30 in WCH 1.120 Review Th 3/29 at 5pm in GRG 102

... Prevention efforts will only be effective if the source can be defined ...
Gene therapy
Gene therapy

... also carries genes for six accessory proteins termed tat, rev, vpr, vpu, nef and vif 11. Using the retrovirus vectors as a model, lentivirus vectors have been made, with the transgene enclosed between the LTRs and a packaging sequence12. Some of the accessory proteins can be eliminated without affec ...
محاضرة 8
محاضرة 8

... account for 95% of all the phages reported in the scientific literature, and possibly make up the majority of phages on the planet. However, other phages occur abundantly in the biosphere, with different virions, genomes and lifestyles. Phages are classified by the International Committee on Taxonom ...
< 1 ... 8 9 10 11 12 13 14 15 16 ... 32 >

Oncolytic virus

An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by lysis, they release new infectious virus particles to help destroy the remaining tumour. Oncolytic viruses are thought not only to cause direct destruction of the tumour cells, but also to stimulate host anti-tumour immune responses.The potential of viruses as anti-cancer agents was first realised in the early twentieth century, although coordinated research efforts did not begin until the 1960s. A number of viruses including adenovirus, reovirus, measles, herpes simplex, Newcastle disease virus and vaccinia have now been clinically tested as oncolytic agents. Most current oncolytic viruses are engineered for tumour selectivity, although there are naturally occurring examples such as reovirus and the SVV-001 Seneca Valley virus, resulting in clinical trials.As of 2011, only limited human trials had been performed.Nevertheless, the drug talimogene laherparepvec (OncoVex, T-VEC) recently (Jan 2012) reported the first positive interim Phase III clinical trial results for an oncolytic virus, making it likely that it will also be the first one approved for use (for the treatment of advanced melanoma). However, skeptics have questioned the clinical relevance of this interim data citing that the awaited overall survival data will be the final judgement and that it is likely that patient benefit will be maximised in combination with other therapies, which this trial did not test. 2015 update: In a combined decision, members of the FDA’s Oncologic Drugs Advisory Committee (ODAC) and Cellular, Tissue and Gene Therapies Advisory Committee (CTGTAC) voted 22-1 to recommend approval of the oncolytic immunotherapy talimogene laherparepvec (T-VEC) as a treatment for patients with advanced melanoma. A final approval decision from the FDA is scheduled by October 27, 2015. Approved in Latvia oncolytic virus RIGVIR was registered in Georgia in February 2015. Melanoma Research published new data on RIGVIR efficacy, showing that early stage melanoma patients treated with oncolytic virus RIGVIR had 4.39–6.57-fold lower mortality than those, who according to melanoma treatment guidelines did not receive virotherapy and were only observed.
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report